Neuroscientific Biopharmaceuticals Ltd (NSB) - Total Liabilities

Latest as of June 2025: AU$149.22K AUD ≈ $105.59K USD

Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) has total liabilities worth AU$149.22K AUD (≈ $105.59K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Neuroscientific Biopharmaceuticals Ltd cash conversion from operations to assess how effectively this company generates cash.

Neuroscientific Biopharmaceuticals Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data. Check Neuroscientific Biopharmaceuticals Ltd (NSB) asset resilience to evaluate the company's liquid asset resilience ratio.

Neuroscientific Biopharmaceuticals Ltd Competitors by Total Liabilities

The table below lists competitors of Neuroscientific Biopharmaceuticals Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Moatech Co. Ltd KQ:033200	Korea	₩7.37 Billion
Firefly Neuroscience, Inc. NASDAQ:AIFF	USA	$2.75 Million
Przedsiebiorstwo Produkcyjno Handlowe Kompap SA WAR:KMP	Poland	zł38.56 Million
Clean TEQ Water Ltd AU:CNQ	Australia	AU$7.72 Million
Yw Company Limited KQ:051390	Korea	₩14.27 Billion
Australian Rare EARTHS Ltd AU:AR3	Australia	AU$2.27 Million
Aquarius Engines AM Ltd TA:AQUA	Israel	ILA5.46 Million
Powercom Co Ltd TW:3043	Taiwan	NT$932.65 Million

Liability Composition Analysis (2016–2025)

This chart breaks down Neuroscientific Biopharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Neuroscientific Biopharmaceuticals Ltd (NSB) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	49.56	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	48.69	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.01	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.01	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Neuroscientific Biopharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual total liabilities of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-06-30	AU$149.22K ≈ $105.59K	+74.16%
2024-06-30	AU$85.68K ≈ $60.63K	-85.66%
2023-06-30	AU$597.36K ≈ $422.67K	-73.06%
2022-06-30	AU$2.22 Million ≈ $1.57 Million	+892.65%
2021-06-30	AU$223.41K ≈ $158.08K	+152.35%
2020-06-30	AU$88.53K ≈ $62.64K	+41.70%
2019-06-30	AU$62.48K ≈ $44.21K	-18.21%
2018-06-30	AU$76.39K ≈ $54.05K	+77.02%
2017-06-30	AU$43.15K ≈ $30.53K	-64.66%
2016-06-30	AU$122.12K ≈ $86.41K	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$24.71 Million

AU$34.92 Million AUD

Market Cap Rank

#24336 Global

#1003 in Australia

Share Price

AU$0.11

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.25

All Time High

AU$0.52